Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.007 Å; R factor = 0.039; wR factor = 0.088; data-to-parameter ratio = 15.7.
In the title compound, [CuI(C 8 H 8 N 2 S)(C 18 H 15 P) 2 ]ÁCH 3 OH, the coordination environment around the Cu I atom is distorted tetrahedral, defined by two P atoms of two triphenylphosphane ligands, one S atom of a 5-methyl-1H-benzimidazole-2(3H)-thione ligand and one I atom. The complex molecules and the methanol solvent molecules are connected via N-HÁ Á ÁO and O-HÁ Á ÁI hydrogen bonds, forming a chain along [010] . An intramolecular N-HÁ Á ÁI hydrogen bond is also observed.
Related literature
For the structures and properties of transition metal complexes with phosphanes, see: Baxter et al. (1994) ; Kitagawa et al. (1995) ; Lewis et al. (1996) . For complexes with a 2-mercapto-5-methylbenzimidazole ligand, see: Ozturk et al. 
Experimental
Crystal data [CuI(C 8 Table 1 Hydrogen-bond geometry (Å , ). Various transition metal complexes with bridging phosphanes or functionalized phosphanes have drawn much attention in recent years for their special structures, novel reactivity performances, catalytic properties and luminescence (Baxter et al., 1994; Kitagawa et al., 1995; Lewis et al., 1996) . The 2-mercapto-5-methylbenzimidazole (MMBI) ligand, with an -SH group and two potential coordination N atoms, is excellent in building supramolecular structures (Ozturk et al., 2009; Schneider et al., 2008) . However, to our best knowledge, Cu(I) complexes with the MMBI ligand have not been reported.
In this paper, one Cu(I) complex with PPh 3 and MMBI is reported.
In the title compound, MMBI acts as a neutral, monodentate ligand with the S atom as a coordination atom. Other sites of the coordination tetrahedron are occupied by two P atoms from two PPh 3 ligands and an iodide anion (Fig. 1) . The Cu -S, Cu-P and Cu-I bond lengths agree with those in [CuI(H 2 itsc)(Ph 3 P) 2 ] (H 2 itsc = isatin-3-thiosemicarbazones) (Lobana et al., 2005) and [CuI(C 4 
A mixture of CuI (0.2 mmol) and 2-mercapto-5-methylbenzimidazole (0.2 mmol) in MeOH and CH 2 Cl 2 (10 ml, v/v = 1:1) was stirred for 2 h. PPh 3 (0.2 mmol) was added to the mixture, which was stirred for another 4 h. The insoluble residues were removed by filtration, and filtrate was evaporated slowly at room temperature for a week to yield colorless crystalline products. 
